BackIbere Pharmaceuticals Overview

Ibere Pharmaceuticals Long Term Debt

Ibere Pharmaceuticals's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Ibere Pharmaceuticals Long Term Debt History

Loading

Ibere Pharmaceuticals vs. peers: Long Term Debt Comparison

Loading

Ibere Pharmaceuticals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ibere Pharmaceuticals (IBER) FAQ

Ibere Pharmaceuticals (IBER) currently reports a long-term debt of $0 as of September 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Ibere Pharmaceuticals's long-term debt history and peer comparisons.

Ibere Pharmaceuticals's long-term debt changed from $0 to $0 (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ibere Pharmaceuticals reported $0 in long-term debt as of September 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ibere Pharmaceuticals, and consider following IBER for alerts when major investors trade the stock.